Literature DB >> 2856861

Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.

J Cuzick, H Stewart, R Peto, M Baum, B Fisher, H Host, J P Lythgoe, G Ribeiro, H Scheurlen, A Wallgren.   

Abstract

An overview of the mortality results of the mature trials in which radiotherapy was a randomized option after simple or radical mastectomy is presented. The principal aim of the overview was to study long-term survival, and recent trials, often including chemotherapy options, have not been included. A total of 7941 patients were entered into these trials and 4148 deaths occurred. No differences were found in survival in the first 10 years of follow-up, in trials employing either radical mastectomy or simple mastectomy. Follow-up information after 10 years came mostly from trials employing radical mastectomy with or without irradiation, and in these trials a significant excess of deaths was observed among patients given radiotherapy (P less than 0.001, all trials; P = 0.002, radical mastectomy trials only). Further data collection will be necessary to determine which causes of death are elevated.

Entities:  

Mesh:

Year:  1987        PMID: 2856861

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  46 in total

1.  Have changing treatment patterns affected outcome for operable breast cancer? Ten-year follow-up in 1288 patients, 1965 to 1978.

Authors:  H S Cody; E H Laughlin; C Trillo; J A Urban
Journal:  Ann Surg       Date:  1991-04       Impact factor: 12.969

2.  Meta-analysis as a manifestation of 'bondförnuft' ('peasant sense').

Authors:  Jan Stjernswärd
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

3.  Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients.

Authors:  R Hansen; B Erickson; R Komaki; N Janjan; J Cox; J F Wilson; T Anderson
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

Review 4.  Radiation enhancement of metastasis: a review.

Authors:  C F von Essen
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

5.  Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. A 6 1/2 year follow-up analysis of a randomized trial of the French Federation of Cancer Centers (F.F.C.C.).

Authors:  J Lacour; A Laplanche; T Delozier; J Berlie; N Mourali; J P Julien; C De Gislain; M Namer; J C Petit; V Denis
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

Review 6.  Meta-analysis in clinical medicine.

Authors:  T C Chalmers
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

7. 

Authors:  P Schäfer
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

8.  Survival following locoregional recurrence after breast conservation therapy for cancer.

Authors:  A Stotter; E N Atkinson; B A Fairston; M McNeese; M J Oswald; C M Balch
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

9.  Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.

Authors:  Pauline T Truong; Ivo A Olivotto; Timothy J Whelan; Mark Levine
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

10.  Role of radiotherapy following total mastectomy in patients with early breast cancer. The Closed Trials Working Party of the CRC Breast Cancer Trials Group.

Authors:  J Houghton; M Baum; J L Haybittle
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.